======= PIAS2 ======= == Gene Information == * **Official Symbol**: PIAS2 * **Official Name**: protein inhibitor of activated STAT 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9063|9063]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75928|O75928]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PIAS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PIAS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603567|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the protein inhibitor of activated STAT family, which function as SUMO E3 ligases and play important roles in many cellular processes by mediating the sumoylation of target proteins. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. Isoforms of the encoded protein enhance the sumoylation of specific target proteins including the p53 tumor suppressor protein, c-Jun, and the androgen receptor. A pseudogene of this gene is located on the short arm of chromosome 4. The symbol MIZ1 has also been associated with ZBTB17 which is a different gene located on chromosome 1. [provided by RefSeq, Aug 2017]. * **UniProt Summary**: Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulator in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway. The effects of this transcriptional coregulation, transactivation or silencing may vary depending upon the biological context and the PIAS2 isoform studied. However, it seems to be mostly involved in gene silencing. Binds to sumoylated ELK1 and enhances its transcriptional activity by preventing recruitment of HDAC2 by ELK1, thus reversing SUMO-mediated repression of ELK1 transactivation activity. Isoform PIAS2-beta, but not isoform PIAS2-alpha, promotes MDM2 sumoylation. Isoform PIAS2-alpha promotes PARK7 sumoylation. Isoform PIAS2-beta promotes NCOA2 sumoylation more efficiently than isoform PIAS2- alpha. Isoform PIAS2-alpha sumoylates PML at'Lys-65' and 'Lys- 160'. {ECO:0000269|PubMed:15920481, ECO:0000269|PubMed:15976810, ECO:0000269|PubMed:22406621}. |zf-MIZ| |SUMO ligase activity| |negative regulation of androgen receptor signaling pathway| |SUMO transferase activity| |regulation of androgen receptor signaling pathway| |androgen receptor signaling pathway| |negative regulation of intracellular steroid hormone receptor signaling pathway| |androgen receptor binding| |RNA polymerase II transcription factor binding| |protein sumoylation| |intracellular steroid hormone receptor signaling pathway| |regulation of intracellular steroid hormone receptor signaling pathway| |transcription coregulator activity| |PML body| |steroid hormone mediated signaling pathway| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |cellular response to steroid hormone stimulus| |transcription coactivator activity| |ubiquitin protein ligase binding| |peptidyl-lysine modification| |response to steroid hormone| |transcription factor binding| |nuclear speck| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |protein modification by small protein conjugation| |zinc ion binding| |response to lipid| |peptidyl-amino acid modification| |response to hormone| |response to organic cyclic compound| |protein modification by small protein conjugation or removal| |cellular response to endogenous stimulus| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |DNA binding| |response to endogenous stimulus| |positive regulation of transcription, DNA-templated| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15381 * **Expression level (log2 read counts)**: 6.01 {{:chemogenomics:nalm6 dist.png?nolink |}}